Tong, H., Huang, Z., Chen, H., Zhou, B., Liao, Y., & Wang, Z. (2020). Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway. Onco Targets Ther.
Chicago Style aipamenaTong, Hongfei, Zhen Huang, Hui Chen, Bin Zhou, Yi Liao, and Zhaohong Wang. "Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway." Onco Targets Ther 2020.
MLA aipamenaTong, Hongfei, et al. "Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway." Onco Targets Ther 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.